Trademark Overview
On Tuesday, May 26, 2026, a trademark application was filed for 1DER with the United States Patent and Trademark Office. The USPTO has given the 1DER trademark a serial number of 99844885. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 26, 2026. This trademark is owned by 1der, Inc.. The 1DER trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Reagents for use in medical genetic testing; Diagnostic preparations for medical use; Diagnostic preparations for medical purposes for detecting genetic predispositions; Diagnostic preparations for use in assessment of genomic analysis for medical use; Diagnostic preparations for in vitro testing for medical use
Medical research services; Scientific research and development; Biotechnology research; Genetic testing for scientific research purposes; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of genomics; Research and development services in the field of biotechnology; Research and development in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Biotechnology research in the field of Genomics, Genetic Editing, Genetic Testing, Genetics, Stem Cell Biology; Consulting services in the field of biotechnology; Biotechnology research in the field of Genomics; Development of new technology for others in the field of Reproductive Biology, Human Reproductive Biology; Development of new technology for others in the field of Assisted Reproductive Technologies, IVF; Development of new technology for others in the field of Reproduction, Genetic Test...
Genetic testing for medical purposes; DNA screening for medical purposes; Structural and functional analysis of genomes for medical purposes; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Providing personalized healthcare and medical information in the nature of genomics, genetic testing and editing; Genetic counseling; Providing medical information to patients and medical professionals in the form of reports in the field of genetic testing results interpretation